Government of China has approved two experimental treatment for COVID-19 vaccine for clinical trials.
The government has now approved early-stage human tests for two experimental vaccines to combat the coronavirus.
The media in Xinhua reported on Tuesday noon.
Information says the vaccine is developed by a Beijing-based unit of Nasdaq-listed Sinovac Biotech, and by the Wuhan Institute of Biological Products, an affiliate of state-owned China National Pharmaceutical Group.
Vaccine needed to stop virus spread
The World Health Organization (WHO) said Monday that a safe and effective vaccine would be needed to fully halt the spread of Covid-19, which has killed more than 114,000 people worldwide.
“Our global connectedness means the risk of re-introduction and resurgence of Covid-19 will continue,” WHO Director-General Tedros Adhanom Ghebreyesus told a virtual briefing from Geneva, stressing that “ultimately, the development and delivery of a safe and effective vaccine will be needed to fully interrupt transmission.”
BY : MOD DEE
